Development of dry powder inhaler containing tadalafil-loaded PLGA nanoparticles

Inhalable dry powders containing poly lactic-co-glycolic acid (PLGA) nanoparticles (NPs) were developed for the delivery of tadalafil (TAD) for treatment of life-treating pulmonary arterial hypertension. Taguchi design was employed to evaluate the effects of different formulation variables on the ph...

Descripción completa

Detalles Bibliográficos
Autores principales: Varshosaz, Jaleh, Taymouri, Somayeh, Hamishehkar, Hamed, Vatankhah, Razieh, Yaghubi, Shadi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465831/
https://www.ncbi.nlm.nih.gov/pubmed/28626480
http://dx.doi.org/10.4103/1735-5362.207203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465831/
https://www.ncbi.nlm.nih.gov/pubmed/28626480
http://dx.doi.org/10.4103/1735-5362.207203

Ejemplares similares